Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the antihypertensive efficacy of a fixed combination of
Irbesartan/HydroChloroThiazide (CoAprovel) in Chinese moderate to severe hypertensive
patients.
The secondary objective is to get systolic blood pressure and diastolic blood pressure goal
attainment rate from CoAprovel in Chinese hypertensive patients.